Latest Insider Transactions at Bio Cor Rx Inc. (BICX)
This section provides a real-time view of insider transactions for Bio Cor Rx Inc. (BICX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of BioCorRx Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of BioCorRx Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Dec 30
2022
|
Louis C. Lucido President |
BUY
Open market or private purchase
|
Direct |
315
+0.18%
|
$315
$1.01 P/Share
|
Dec 12
2022
|
Louis C. Lucido President |
BUY
Open market or private purchase
|
Direct |
5,000
+1.4%
|
$0
$0.84 P/Share
|
Oct 06
2022
|
Louis C. Lucido President |
BUY
Open market or private purchase
|
Direct |
580
+0.23%
|
$580
$1.84 P/Share
|
Oct 05
2022
|
Louis C. Lucido President |
BUY
Open market or private purchase
|
Direct |
1,000
+1.18%
|
$2,000
$2.02 P/Share
|
Sep 30
2022
|
Joseph J Galligan |
BUY
Grant, award, or other acquisition
|
Direct |
2,450
+5.65%
|
-
|
Sep 30
2022
|
Kent Emry |
BUY
Grant, award, or other acquisition
|
Direct |
2,450
+2.39%
|
-
|
Sep 30
2022
|
Louis C. Lucido President |
BUY
Grant, award, or other acquisition
|
Direct |
2,450
+2.87%
|
-
|
Sep 30
2022
|
Luisa Ingargiola |
BUY
Grant, award, or other acquisition
|
Direct |
2,450
+7.95%
|
-
|
Sep 30
2022
|
Lourdes Felix CEO and CFO |
BUY
Grant, award, or other acquisition
|
Direct |
2,450
+4.28%
|
-
|
Sep 06
2022
|
Louis C. Lucido President |
BUY
Open market or private purchase
|
Direct |
10
+0.01%
|
$20
$2.1 P/Share
|
Aug 31
2022
|
Louis C. Lucido President |
BUY
Open market or private purchase
|
Direct |
610
+0.75%
|
$1,220
$2.12 P/Share
|
Aug 29
2022
|
Louis C. Lucido President |
BUY
Open market or private purchase
|
Direct |
3,268
+2.02%
|
$6,536
$2.11 P/Share
|
Aug 26
2022
|
Louis C. Lucido President |
BUY
Open market or private purchase
|
Direct |
560
+0.73%
|
$1,120
$2.12 P/Share
|
Aug 25
2022
|
Louis C. Lucido President |
BUY
Open market or private purchase
|
Direct |
500
+0.65%
|
$1,000
$2.18 P/Share
|
Jun 30
2022
|
Kent Emry |
BUY
Grant, award, or other acquisition
|
Direct |
2,092
+2.1%
|
-
|
Jun 30
2022
|
Joseph J Galligan |
BUY
Grant, award, or other acquisition
|
Direct |
2,092
+5.16%
|
-
|
Jun 30
2022
|
Louis C. Lucido President |
BUY
Grant, award, or other acquisition
|
Direct |
2,092
+2.7%
|
-
|
Jun 30
2022
|
Lourdes Felix CEO and CFO |
BUY
Grant, award, or other acquisition
|
Direct |
2,092
+3.85%
|
-
|
Jun 30
2022
|
Luisa Ingargiola |
BUY
Grant, award, or other acquisition
|
Direct |
2,092
+7.47%
|
-
|
Mar 31
2022
|
Joseph J Galligan |
BUY
Grant, award, or other acquisition
|
Direct |
1,408
+3.59%
|
-
|
Mar 31
2022
|
Lourdes Felix CEO and CFO |
BUY
Grant, award, or other acquisition
|
Direct |
1,408
+2.73%
|
-
|
Mar 31
2022
|
Louis C. Lucido President |
BUY
Grant, award, or other acquisition
|
Direct |
1,408
+1.88%
|
-
|
Mar 31
2022
|
Luisa Ingargiola |
BUY
Grant, award, or other acquisition
|
Direct |
1,408
+5.29%
|
-
|
Mar 31
2022
|
Kent Emry |
BUY
Grant, award, or other acquisition
|
Direct |
1,408
+1.45%
|
-
|
Dec 31
2021
|
Joseph J Galligan |
BUY
Grant, award, or other acquisition
|
Direct |
1,141
+3.04%
|
-
|
Dec 31
2021
|
Luisa Ingargiola |
BUY
Grant, award, or other acquisition
|
Direct |
1,141
+4.57%
|
-
|
Dec 31
2021
|
Kent Emry |
BUY
Grant, award, or other acquisition
|
Direct |
1,141
+1.2%
|
-
|
Dec 31
2021
|
Louis C. Lucido President |
BUY
Grant, award, or other acquisition
|
Direct |
1,141
+1.56%
|
-
|
Dec 31
2021
|
Lourdes Felix CEO and CFO |
BUY
Grant, award, or other acquisition
|
Direct |
1,141
+2.28%
|
-
|
Oct 19
2021
|
Louis C. Lucido President |
BUY
Open market or private purchase
|
Direct |
1,550
+2.14%
|
$4,650
$3.2 P/Share
|
Sep 30
2021
|
Luisa Ingargiola |
BUY
Grant, award, or other acquisition
|
Direct |
1,381
+5.74%
|
-
|
Sep 30
2021
|
Joseph J Galligan |
BUY
Grant, award, or other acquisition
|
Direct |
1,381
+3.77%
|
-
|
Sep 30
2021
|
Kent Emry |
BUY
Grant, award, or other acquisition
|
Direct |
1,381
+1.46%
|
-
|
Sep 30
2021
|
Lourdes Felix CEO and CFO |
BUY
Grant, award, or other acquisition
|
Direct |
1,381
+2.82%
|
-
|
Sep 30
2021
|
Louis C. Lucido President |
BUY
Grant, award, or other acquisition
|
Direct |
1,381
+1.98%
|
-
|
Jun 30
2021
|
Luisa Ingargiola |
BUY
Grant, award, or other acquisition
|
Direct |
1,210
+5.38%
|
-
|
Jun 30
2021
|
Louis C. Lucido President |
BUY
Grant, award, or other acquisition
|
Direct |
1,210
+1.77%
|
-
|
Jun 30
2021
|
Joseph J Galligan |
BUY
Grant, award, or other acquisition
|
Direct |
1,210
+3.45%
|
-
|
Jun 30
2021
|
Lourdes Felix CEO and CFO |
BUY
Grant, award, or other acquisition
|
Direct |
1,210
+2.55%
|
-
|
Jun 30
2021
|
Kent Emry |
BUY
Grant, award, or other acquisition
|
Direct |
1,210
+1.3%
|
-
|
Mar 31
2021
|
Kent Emry |
BUY
Grant, award, or other acquisition
|
Direct |
2,315
+2.49%
|
-
|
Mar 31
2021
|
Joseph J Galligan |
BUY
Grant, award, or other acquisition
|
Direct |
1,157
+3.42%
|
-
|
Mar 31
2021
|
Brady James Granier |
BUY
Grant, award, or other acquisition
|
Direct |
2,326
+2.41%
|
-
|
Mar 31
2021
|
Luisa Ingargiola |
BUY
Grant, award, or other acquisition
|
Direct |
2,326
+10.38%
|
-
|
Mar 31
2021
|
Lourdes Felix CEO and CFO |
BUY
Grant, award, or other acquisition
|
Direct |
2,326
+4.91%
|
-
|
Mar 31
2021
|
Louis C. Lucido President |
BUY
Grant, award, or other acquisition
|
Direct |
2,315
+3.39%
|
-
|
Feb 26
2021
|
Louis C. Lucido President |
BUY
Open market or private purchase
|
Indirect |
562,500
+50.0%
|
$1,125,000
$2.0 P/Share
|
Jan 22
2021
|
Louis C. Lucido President |
BUY
Open market or private purchase
|
Direct |
2,000
+3.05%
|
$2,000
$1.44 P/Share
|
Dec 31
2020
|
Louis C. Lucido President |
BUY
Grant, award, or other acquisition
|
Direct |
4,901
+1.84%
|
-
|
Dec 31
2020
|
Kent Emry |
BUY
Grant, award, or other acquisition
|
Direct |
4,901
+5.27%
|
-
|